Role of Antibodies Against Glutamate Receptors and Double Stranded DNA in Epilepsy Patients
NCT00317668 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 250
Last updated 2007-05-01
Summary
The investigators will check the serum of epilepsy patients for antibodies against glutamate receptors and double stranded DNA. They will characterise the patients (by the kind of epilepsy, autoimmune disease comorbidity, and cognitive profile).
Conditions
Sponsors & Collaborators
-
Hadassah Medical Organization
lead OTHER
Principal Investigators
-
Dana Ekstein, MD · Hadassah Medical Organization
Eligibility
- Min Age
- 18 Years
- Max Age
- 90 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2006-11-30
Countries
- Israel
Study Locations
More Related Trials
-
Study of Specimens Obtained During Epilepsy Surgery
NCT00025714 ·Status: COMPLETED
-
Human Epilepsy Project 3
NCT05374928 ·Status: ACTIVE_NOT_RECRUITING
-
Safety and Feasibility of Using Epicall for Monitoring Pre-seizure Biomarkers
NCT01436695 ·Status: UNKNOWN
-
Antibodies Causing Epilepsy Syndromes: The ACES Study.
NCT02802475 ·Status: COMPLETED
-
Retigabine (Adjunctive Therapy) Efficacy and Safety Study for Partial Onset Refractory Seizures in Epilepsy
NCT00232596 ·Status: COMPLETED ·Phase: PHASE3
-
Association Between Ferroptosis and Epilepsy
NCT05269901 ·Status: COMPLETED
-
Evaluation and Treatment of Patients With Epilepsy
NCT00013845 ·Status: TERMINATED
-
A Study of the Prevalence of Headache in Epileptic Patients
NCT00277368 ·Status: COMPLETED
-
An Open-Label Extension Study to Evaluate the Safety and Effectiveness of RWJ 333369 in Patients With Epilepsy
NCT00210652 ·Status: COMPLETED ·Phase: PHASE2
-
Prevalence and Pattern of Headache in Pediatric Epilepsy
NCT06868251 ·Status: NOT_YET_RECRUITING
-
Anti-Epilepsy Medication Valproate Administered Via ICV Route and Catheters and Pumps for CSF Infusion
NCT04529954 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Seizures and Traumatic Brain Injury Rehabilitation
NCT05823168 ·Status: COMPLETED
-
Efficacy, Safety and Pharmacokinetics of ES-481 in Adult Patients With Drug Resistant Epilepsy
NCT04714996 ·Status: UNKNOWN ·Phase: PHASE2
-
Nucleotide Protein -3 in Epileptic Children
NCT04219930 ·Status: UNKNOWN
-
Study of [11C]DPA-713 for Temporal Lobe Epilepsy
NCT01793532 ·Status: COMPLETED
-
Study of Predictors of Response to Anti Epilepsy in Epilepsy
NCT02883712 ·Status: TERMINATED
-
Biology of Juvenile Myoclonic Epilepsy
NCT03400371 ·Status: RECRUITING
-
An Open-Label Extension Study of the Effectiveness and Safety of the Investigational Compound RWJ-333369 in Patients With Epilepsy
NCT00210522 ·Status: COMPLETED ·Phase: PHASE2
-
Role of Hormones in Susceptibility to Seizures in Women With Epilepsy
NCT00044252 ·Status: COMPLETED
-
PRX-00023 Therapy in Localization-Related Epilepsy
NCT01281956 ·Status: TERMINATED ·Phase: PHASE2
-
Phase III Randomized, Double-Blind, Placebo-Controlled Study of Oral Topiramate for Lennox-Gastaut Syndrome
NCT00004776 ·Status: COMPLETED ·Phase: PHASE3
-
Genetics of Rolandic Epilepsy
NCT00282854 ·Status: COMPLETED
-
Acute Sympotomatic Seizure Secondary to Autoimmune Encephalitis and Autoimmune-associated Epilepsy
NCT05422664 ·Status: ENROLLING_BY_INVITATION
-
Seizures Post Intracerebral Hemorrhage
NCT01115959 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of Lu AG06466 in Participants With Treatment Resistant Focal Epilepsy
NCT05081518 ·Status: TERMINATED ·Phase: PHASE1